CSL Limited (CSLLY)
(Delayed Data from OTC)
$105.63 USD
+2.27 (2.20%)
Updated Aug 23, 2024 03:51 PM ET
4-Sell of 5 4
F Value B Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CSLLY 105.63 +2.27(2.20%)
Will CSLLY be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CSLLY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CSLLY
EXEL or CSLLY: Which Is the Better Value Stock Right Now?
GMAB vs. CSLLY: Which Stock Is the Better Value Option?
CSLLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
New Strong Sell Stocks for August 14th
5 Diverse Medical Stocks to Buy for 2023 and Beyond
Other News for CSLLY
CSL Limited: Good Results Overshadowed By Below-Expectations Guidance
Jarden Reaffirms Their Buy Rating on CSL (CMXHF)
RBC Capital Remains a Hold on CSL (CMXHF)
CSL Limited (CSLLY) Q4 2024 Earnings Call Transcript
Wilsons Reaffirms Their Hold Rating on CSL (CMXHF)